KYNB - FIBROGEN INC
6.84
-0.045 -0.658%
Share volume: 54,751
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$6.88
-0.04
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-06-2024 | 08-06-2024 | 11-12-2024 | 03-17-2025 | 05-12-2025 | 08-11-2025 | 11-10-2025 | |
| Cash flow financing | -165.000 K | 32.000 K | -127.000 K | 5.000 K | -88.000 K | -9.000 K | -85.917 M | |
| Other financing cash flows | -153.000 K | -76.000 K | -147.000 K | -18.000 K | -42.000 K | -9.000 K | -14.000 K | |
| Cash flow | -8.177 M | 32.402 M | -7.748 M | -28.738 M | 2.615 M | 12.660 M | -604.000 K | |
| Net income | -32.933 M | -15.544 M | -17.084 M | 17.982 M | 4.639 M | -7.603 M | 200.636 M | |
| Depreciation | 810.000 K | 772.000 K | 730.000 K | 342.000 K | 318.000 K | 212.000 K | 183.000 K | |
| Changes in inventories | -13.786 M | 0.000 | 0.000 | 0.000 | -2.859 M | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 51.276 M | 72.239 M | 755.000 K | 1.723 M | -16.000 K | -13.000 K | 87.160 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 29.000 K | 11.000 K | -755.000 K | -65.000 K | 16.000 K | 13.000 K | 9.000 K | |
| Cash Change | -7.954 M | 34.980 M | -9.711 M | -28.825 M | 4.022 M | 13.641 M | -1.866 M |